Profound Medical Corp.

NASDAQ: PROF · Real-Time Price · USD
4.33
-1.21 (-21.84%)
At close: Aug 15, 2025, 3:59 PM
4.37
0.92%
After-hours: Aug 15, 2025, 05:13 PM EDT

Profound Medical Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
46.43M 54.91M 27.12M 34.08M 41.18M 26.21M 33.63M 39.27M 42.98M 46.52M 46.21M 53.23M 60.12M 67.15M 72.22M 73.77M 78.51M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 3.53M 3.26M 4.58M 4.58M n/a n/a n/a
Other Long-Term Assets
n/a 499.00 n/a n/a n/a n/a n/a n/a n/a n/a 2.57M 2.53M 3.67M 3.62M n/a n/a n/a
Receivables
5.97M 7.04M 7.03M 7.16M 6.51M 7.29M 6.62M 6.59M 7M 6.34M 3.46M 3.46M 1.84M 1.41M 7.95M 7.54M 6.34M
Inventory
6.79M 5.8M 6.43M 6.73M 6.98M 6.99M 7.42M 8.06M 8.13M 7.94M 7.44M 7.99M 7.8M 7.41M 6.99M 7.39M 7.41M
Other Current Assets
718K 3.45K n/a n/a n/a 13.35M n/a n/a n/a 21.95M n/a n/a 17.6M 20.3M n/a n/a n/a
Total Current Assets
59.91M 69.06M 40.88M 48.49M 55.54M 41.9M 48.32M 54.69M 58.97M 62.02M 57.55M 65.19M 70.65M 77.13M 87.27M 89.14M 93.01M
Property-Plant & Equipment
651K 820.51K 1.02M 1.17M 1.41M 1.52M 1.6M 1.52M 1.65M 1.72M 1.75M 1.76M 2.04M 1.9M 2.06M 2.2M 2.22M
Goodwill & Intangibles
214K 261K 329K 374K 428K 490K 530K 592K 630K 680K 3.21M 3.54M 3.92M 4.12M 4.25M 4.5M 4.54M
Total Long-Term Assets
952K 1.17M 1.35M 1.54M 1.84M 2.02M 2.13M 2.11M 2.28M 2.4M 7.53M 7.83M 9.62M 9.65M 6.3M 6.7M 6.75M
Total Assets
60.86M 70.23M 42.23M 50.03M 57.38M 43.91M 50.44M 56.81M 61.24M 64.42M 64.08M 73.03M 80.27M 86.78M 93.56M 95.84M 99.77M
Account Payables
1.05M 1.32M 3.4M 2.67M 2.88M 3.28M 2.02M 2.42M 2.06M 2.03M 3.5M 3.12M 3.47M 3.18M 2.17M 2.31M 2.5M
Deferred Revenue
636K 419K 799.73K 676K 644K 721K 673K 652K 698K 471K 479K 505K 627K 477K 554K 852K 456K
Short-Term Debt
261K 1.74M 2.2M 2.02M 8.78M 2.79M 1.91M 9.71M 924K 523K n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities
2.4M 1.03M 1.87M 1.34M -2.3M -683.74K 1.83M 1.17M 507K 621K -897K -552.08K -491.86K 248K 465K 503K 594K
Total Current Liabilities
5.29M 6.57M 6.67M 5.63M 10.27M 6.37M 5.19M 10.98M 4.77M 4.18M 3.32M 3.32M 3.86M 4.16M 3.6M 4.07M 3.98M
Long-Term Debt
4.49M 2.92M 3.4M 3.94M n/a 7.39M 8.11M n/a 9.43M 10.11M n/a n/a 1.36M 1.43M 1.32M 1.45M 1.49M
Other Long-Term Liabilities
72K 53.63M 73.88K n/a n/a -4.78M -2.77M 1.23M -3.21M -3.46M -221K 1.37M -1.36M -1.43M -1.32M -1.45M -1.49M
Total Long-Term Liabilities
4.78M 56.81M 4.49M 5.16M 1.26M 6.37M 6.7M 1.46M 7.73M 8.23M 649K 1.82M 1.95M 2M 1.95M 1.89M 2.36M
Total Liabilities
10.07M 9.81M 11.17M 10.79M 11.52M 12.73M 11.88M 12.44M 12.51M 12.42M 3.96M 5.14M 5.81M 6.16M 5.55M 5.96M 6.34M
Total Debt
4.88M 5.12M 6.23M 6.65M 7.24M 7.94M 8.13M 8.29M 8.15M 8.23M 1.1M 1.23M 1.34M 1.38M 1.45M 1.57M 1.62M
Common Stock
281.64M 281.55M 235.67M 230.84M 232.76M 217.39M 212.61M 216.09M 209.4M 205.82M 203.4M 216.04M 222.8M 219.58M 218.44M 219.06M 215.27M
Retained Earnings
-255.89M -245.17M -240.41M -231.05M -224.13M -217.93M -209.02M -203.46M -196.1M -189.36M -179.84M -174.84M -168.91M -160.69M -150.53M -144.54M -137.49M
Comprehensive Income
2.85M 2.74M 16.39M 19.31M 17.24M 12.03M 16.59M 12.67M 16.79M 16.84M 19.74M 8.63M 2.45M 4.75M 5.58M 1.65M 3.58M
Shareholders Equity
50.79M 60.42M 31.06M 39.24M 45.86M 31.18M 38.56M 44.37M 48.73M 52M 60.12M 67.88M 74.46M 80.62M 88.01M 89.88M 93.43M
Total Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 3.53M 3.26M 4.58M 4.58M n/a n/a n/a